Using orthotopic GBM mouse models and IL13Rα2-CAR-T cells, the CD4+ CAR-T cell subset was found to be more effective than the CD8+ CAR-T cells, which were rapidly exhausted (82). This evidence concerns the gene CD4 and glioblastoma.